AMO pulls lens care solution

Article

AMO is voluntarily recalling its Complete MoisturePlus contact lens solutions after receiving data from the US Centers for Disease Control and Prevention (CDC) linking the solution with an increase in the occurrence of the eye infection, acanthamoeba keratitis.

AMO is voluntarily recalling its Complete MoisturePlus contact lens solutions after receiving data from the US Centers for Disease Control and Prevention (CDC) linking the solution with an increase in the occurrence of the eye infection, acanthamoeba keratitis (AK).

CDC data from interviews with 46 patients who developed AK, found that 39 were soft contact lens wearers and 21 of these reported using Complete MoisturePlus products. The CDC has estimated the risk of developing AK is at least seven times greater for those using the AMO solution than for those using alternative solutions. However, there is no evidence to suggest that the recall is related to product contamination and does not apply to any other AMO contact lens care products.

Contact lens wearers are advised to see their doctor if they have any of the following symptoms: eye pain, redness, blurred vision, sensitivity to light, the sensation of something in the eye or excessive tearing.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.